FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

H J Harkins Company Inc dba Pharma Pac Ranitidine Recall

Ranitidine, 150 mg Tablets, a) 7 count, b) 14 count, c) 20 count, d) 30 count, e) 60 count

H J Harkins Company Inc dba Pharma Pac · Grover Beach, CA

Risk level
Class II
Reported by FDA
Jan 29, 2020
Recall ID
D-0793-2020
Check your lot numberHow we source this data

Summary

H J Harkins Company Inc dba Pharma Pac recalled Ranitidine starting Jan 6, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0793-2020 on Jan 29, 2020. Reason: CGMP Deviations: Presence of NDMA impurity detected in product. Status: Terminated.

Why it was recalled

CGMP Deviations: Presence of NDMA impurity detected in product.

Product description

Ranitidine, 150 mg Tablets, a) 7 count, b) 14 count, c) 20 count, d) 30 count, e) 60 count; Rx, Only, H.J. Harkins Company, Inc. dba Pharma Pac Grover Beach, CA 93433 NDC #s: 52959-0502-07, 52959-0502-14, 52959-0502-20, 52959-0502-30 and 52959-0502-60

Lot numbers, UPCs & expiration codes

Lot #s: RAN63KG Exp. 05/20, RAN64KG Exp. 10/20, RAN65KG Exp. 11/20, RAN66KG Exp. 05/21

Where it was sold

Distributed to Physicians in the following states: CA, FL, NC, and SC.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0793-2020
Classification
Class II
Status
Terminated
Recall initiated
Jan 6, 2020
FDA report date
Jan 29, 2020
Quantity
7,212 tablets
Recall type
Voluntary: Firm initiated
Recalling firm
H J Harkins Company Inc dba Pharma Pac

Original FDA data

Every field from FDA enforcement report D-0793-2020, exactly as published.

Show all FDA fields
City
Grover Beach
State
CA
Status
Terminated
Country
United States
Event ID
84637
Address
1400 W Grand Ave Ste F
Code information
Lot #s: RAN63KG Exp. 05/20, RAN64KG Exp. 10/20, RAN65KG Exp. 11/20, RAN66KG Exp. 05/21
Postal code
93433-4221
Report date
Jan 29, 2020
Product type
Drugs
Recall number
D-0793-2020
Classification
Class II
Recalling firm
H J Harkins Company Inc dba Pharma Pac
Product quantity
7,212 tablets
Termination date
Dec 15, 2023
Reason for recall
CGMP Deviations: Presence of NDMA impurity detected in product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Ranitidine, 150 mg Tablets, a) 7 count, b) 14 count, c) 20 count, d) 30 count, e) 60 count; Rx, Only, H.J. Harkins Company, Inc. dba Pharma Pac Grover Beach, CA 93433 NDC #s: 52959-0502-07, 52959-0502-14, 52959-0502-20, 52959-0502-30 and 52959-0502-60
Distribution pattern
Distributed to Physicians in the following states: CA, FL, NC, and SC.
Recall initiation date
Jan 6, 2020
Initial firm notification
E-Mail
Center classification date
Jan 20, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0793-2020, published Jan 29, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls